MDGL

#778

Madrigal Pharmaceuticals, Inc. Common Stock

432.0000

-0.54%

Сектор:

Базовая:

Валюта прибыли:

Дневной диапазон

Годовой диапазон

Дневное изменение

-0.54%

Месячное изменение

-14.35%

6-месячное изменение

+1.98%

Годовое изменение

+1.98%

Предыдущее закрытие

434.3600

Open

432.0000

Bid

Ask

Low

432.0000

High

432.0000

Объем

139

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 66.98 M104.49 M88.89 M47.05 M-79.85 M133.46 M 189.55 M Cash from investing activities 202.39 M47.95 M163.88 M47.86 M-207 M27.58 M 32.32 M Cash from financing activities 7.46 M19.77 M8.64 M1.74 M236.65 M8.96 M 255.98 M Free cash flow 66.2 M104.29 M88.89 M47.05 M-83.71 M133.85 M 186.09 M

MDGL

Financials

Новости

Madrigal: The Easiest Money May Have Been Made (NASDAQ:MDGL)

Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)

H.C. Wainwright подтверждает рейтинг акций Madrigal Pharmaceuticals на уровне «покупать»

H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy

Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down

Lam Research, Goldman Sachs among market cap stock movers on Thursday

Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript

Oracle, Deere among market cap stock movers on Thursday

Madrigal Q4 2025 slides: Rezdiffra nears $1B in first year sales despite EPS miss

Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates

Акции Madrigal Pharma упали более чем на 5% из-за убытков за 4 кв.

Madrigal Pharma shares fall over 5% as Q4 earnings miss overshadows revenue beat